Eli Lilly and
LLY | NYSE
$1,417.54
+$43.84 (+3.19%)
At close: Oct 30, 2026, 4:02 PM ET
$1,412.34
-$5.20 (-0.37%)
Pre-market:
Nov 2, 2026, 7:19 AM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 86.46B | 79.67B | 72.25B | 65.18B | 59.42B | 53.26B | 49B | 45.04B | 40.86B | 38.92B | 35.93B | 34.12B | 32.07B | 29.52B | 27.69B | 28.54B | 29.24B | 29.07B | 29.32B | 28.32B | 27.76B | 26.73B | 25.49B |
Cost of Revenue | 18.33B | 13.23B | 12.41B | 11.05B | 10.09B | 9.25B | 8.97B | 8.42B | 7.8B | 7.49B | 7.13B | 7.08B | 6.84B | 6.56B | 6.18B | 6.63B | 7.13B | 6.98B | 7.51B | 7.31B | 6.98B | 6.88B | 6.15B |
Gross Profit | 68.13B | 66.44B | 59.84B | 54.13B | 49.34B | 44.01B | 40.03B | 36.62B | 33.06B | 31.43B | 28.8B | 27.04B | 25.23B | 22.95B | 21.51B | 21.91B | 22.11B | 22.09B | 21.82B | 21.01B | 20.78B | 19.85B | 19.34B |
Operating Income | 40.13B | 39.61B | 34.17B | 29.7B | 26.39B | 22.44B | 19.84B | 17.27B | 14.78B | 13.89B | 11.81B | 10.79B | 9.8B | 8.3B | 7.7B | 8.65B | 8.92B | 9.01B | 8.78B | 7.87B | 7.79B | 7.15B | 7.11B |
Interest Income | n/a | 65M | 105M | 153.3M | 197.6M | 180.4M | 177.7M | 175.2M | 175.4M | 176.5M | 185.2M | 173.6M | 154.6M | 125.8M | 90M | 62.8M | 44.7M | 31.6M | 26.8M | 25.3M | 23.7M | 22.5M | 24.2M |
Pretax Income | 34.77B | 33.6B | 31.13B | 25.73B | 22.5B | 16.86B | 13.6B | 12.68B | 10.15B | 8.99B | 7.56B | 6.55B | 6.14B | 7.28B | 6.28B | 6.81B | 6.55B | 6.23B | 6.73B | 6.16B | 6.78B | 6.98B | 7.03B |
Net Income | 27.58B | 26.71B | 25.28B | 20.64B | 18.41B | 13.8B | 11.11B | 10.59B | 8.37B | 7.34B | 6.14B | 5.24B | 4.99B | 6.5B | 5.69B | 6.24B | 6.03B | 5.69B | 6.13B | 5.58B | 5.97B | 6.07B | 6.09B |
Selling & General & Admin | 12.62B | 12.24B | 11.56B | 11.09B | 10.39B | 9.75B | 9B | 8.36B | 7.75B | 7.34B | 7.14B | 6.94B | 6.68B | 6.52B | 6.24B | 6.07B | 6.04B | 6.02B | 6.1B | 6.14B | 6.12B | 6.07B | 5.87B |
Research & Development | 15.38B | 14.6B | 14.11B | 13.34B | 12.56B | 11.83B | 11.2B | 10.99B | 10.53B | 10.21B | 9.85B | 9.31B | 8.75B | 8.14B | 7.57B | 7.19B | 7.15B | 7.06B | 6.93B | 6.99B | 6.87B | 6.63B | 6.37B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 28B | 26.83B | 25.67B | 24.43B | 22.94B | 21.57B | 20.2B | 19.35B | 18.28B | 17.54B | 17B | 16.25B | 15.43B | 14.66B | 13.8B | 13.26B | 13.19B | 13.08B | 13.03B | 13.13B | 12.99B | 12.7B | 12.23B |
Interest Expense | 800M | 979.6M | 883.6M | 795.3M | 897M | 910.1M | 844.7M | 780.6M | 694.1M | 626M | 562.7M | 485.9M | 431.7M | 388.6M | 349.5M | 331.6M | 329M | 331.1M | 336.8M | 339.7M | 347.5M | 353.5M | 354.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | -800K | -800K | -800K | -800K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 46.33B | 40.06B | 38.08B | 35.48B | 33.03B | 30.82B | 29.17B | 27.77B | 26.08B | 25.03B | 24.12B | 23.34B | 22.27B | 21.22B | 19.99B | 19.89B | 20.32B | 20.06B | 20.54B | 20.45B | 19.97B | 19.58B | 18.38B |
Income Tax Expense | 7.19B | 6.88B | 5.85B | 5.09B | 4.09B | 3.06B | 2.49B | 2.09B | 1.78B | 1.65B | 1.42B | 1.31B | 1.15B | 783M | 595.7M | 561.6M | 516.7M | 538.1M | 603.4M | 573.8M | 812.3M | 905.9M | 933.9M |
Shares Outstanding (Basic) | 891.9M | 892.4M | 894.5M | 898M | 896.9M | 897.9M | 897.99M | 897.54M | 901M | 900.9M | 900.8M | 899.38M | 949.3M | 949.29M | 949.27M | 950.18M | 900.7M | 900.3M | 950.61M | 953.65M | 956.59M | 907.3M | 959.48M |
Shares Outstanding (Diluted) | 893.4M | 893.7M | 895.9M | 898M | 898.8M | 899.79M | 900.6M | 903.16M | 905M | 904.2M | 903.8M | 903.98M | 949.3M | 949.29M | 949.27M | 950.18M | 903.8M | 902.9M | 950.61M | 953.65M | 956.59M | 910.4M | 959.48M |
EPS (Basic) | 30.89 | 29.89 | 28.23 | 23.02 | 20.51 | 15.36 | 12.35 | 11.77 | 9.29 | 8.15 | 6.72 | 5.65 | 5.26 | 6.93 | 6.13 | 6.71 | 6.48 | 6.03 | 6.50 | 5.91 | 6.31 | 6.41 | 6.36 |
EPS (Diluted) | 30.81 | 29.80 | 28.15 | 22.95 | 20.44 | 15.30 | 12.29 | 11.71 | 9.25 | 8.12 | 6.70 | 5.64 | 5.26 | 6.93 | 6.12 | 6.70 | 6.47 | 6.02 | 6.50 | 5.91 | 6.31 | 6.41 | 6.36 |
EBITDA | 44.33B | 43.3B | 37.81B | 33.29B | 26.89B | 21.26B | 17.88B | 15.23B | 12.51B | 11.23B | 9.69B | 8.57B | 8.09B | 9.14B | 8.08B | 8.66B | 8.47B | 8.17B | 8.7B | 8.04B | 8.6B | 8.78B | 8.78B |
EBIT | 33.79B | 41.21B | 35.77B | 31.29B | 25B | 19.37B | 16.05B | 13.46B | 10.84B | 9.62B | 8.12B | 7.04B | 6.57B | 7.67B | 6.63B | 7.14B | 6.88B | 6.56B | 7.07B | 6.5B | 7.13B | 7.33B | 7.38B |
Depreciation & Amortization | 1.63B | 2.1B | 2.04B | 2B | 1.9B | 1.89B | 1.83B | 1.77B | 1.67B | 1.61B | 1.57B | 1.53B | 1.51B | 1.47B | 1.45B | 1.52B | 1.59B | 1.61B | 1.63B | 1.55B | 1.47B | 1.45B | 1.4B |
Add to Watchlist
Select watchlists to add or remove LLY